Comparative studies of 177Lu–EDTMP and 177Lu–DOTMP as potential agents for palliative radiotherapy of bone metastasis
- 1 September 2008
- journal article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 66 (9) , 1196-1205
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 177Lu-DOTMP: A viable agent for palliative radiotherapy of painful bone metastasisRadiochimica Acta, 2008
- Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small jointsNuclear Medicine Communications, 2006
- Preparation and preliminary biological evaluation of a 177Lu labeled nitroimidazole derivative for possible use in targeted tumor therapyRadiochimica Acta, 2006
- Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxiaBioorganic & Medicinal Chemistry, 2004
- Biodistribution of Radioiodinated Adenovirus Fiber Protein Knob Domain after Intravenous Injection in MiceJournal of Virology, 2004
- 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliationApplied Radiation and Isotopes, 2002
- 177Lu labelled polyaminophosphonates as potential agents for bone pain palliationNuclear Medicine Communications, 2002
- Production of 105Rh–EDTMP and its bone accumulationApplied Radiation and Isotopes, 2000
- Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsChemical Reviews, 1999
- 177Lu-EDTMPNuclear Medicine Communications, 1998